The Development Of A New Injectable Asthma Medicine? | The Almagest

The Development Of A New Injectable Asthma Medicine? | The Almagest: Rumour has it that there are drug manufacturers making a “bio race” out of a recent medical development. They are trying to develop a brand new injectable “bio tech” medicine for people whom suffer from terribly restricting cases of asthma, but happen to enjoy the use of inhalers and such. GlaxoSmithKline is the apparent “forerunner” when it comes to the development of this brand new medicine, seeing as they are already known as the leaders of asthma treatments and medicines. Although they have first place on lock down, there are plenty of companies whom feel like they should be on top, names like Roche, AstraZeneca, Sanofi and Teva come into mind, as Reuters reported their names specifically.